Effect of ethanol extracts of Antrodia cinnamomea on head and neck squamous cell carcinoma cell line

被引:0
|
作者
Liu, Li [1 ]
Wang, Chen [2 ]
机构
[1] Anhui Med Coll, Hefei, Peoples R China
[2] Fuyang Vocat Tech Coll, Fuyang, Peoples R China
关键词
Antrodia cinnamomea; Head and neck squamous cell carcinoma cells; Proliferation; Invasion; Migration; STEM-LIKE CELLS; CANCER; THERAPY;
D O I
10.1590/1414-431X20208694
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Head and neck squamous cell carcinoma (HNSCC) is one of the most common malignant tumors. Ethanol extract of Antrodia cinnamomea (EEA) has been widely studied for its health benefits including anticancer effects. The purpose of this study was to assess the effects of EEA on HNSCC. Cell proliferation, transwell, and wound healing assays were performed. The impact of EEA on tumor growth was investigated using a xenograft model. Expressions of migration-related proteins (MMP-2, MMP-9, TIMP-1, and TIMP-2) and apoptosis-related proteins (cleaved caspase-9 and cleaved PARP) were determined using western blot analysis. The results indicated that EEA significantly inhibited the capacities of proliferation, invasion, and migration of HNSCC cells in a dose-dependent manner. Cleaved caspase-9 and cleaved PARP expressions were increased in cells treated with an increasing concentration of EEA, which suggested that EEA induced apoptosis of HNSCC. MMP-2 and MMP-9 were downregulated when cells were administered EEA, while TIMP-1 and TIMP-2 were not affected, which uncovered the mechanisms mediating the EEA-induced inhibition on cell invasion and migration. The animal experiment also suggested that EEA inhibited tumor growth. Our study confirmed the inhibitive effects of EEA on cell proliferation, invasion, and migration of HNSCC in vitro and in vivo, providing the basis for further study of the application of EEA as an effective candidate for cancer treatment.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Recurrent head and neck squamous cell carcinoma
    Wu, S-Y.
    ANNALS OF ONCOLOGY, 2016, 27
  • [32] Cutaneous squamous cell carcinoma of the head and neck
    Deutsch, Jochen
    Dippel, Edgar
    Delank, K. -Wolfgang
    LARYNGO-RHINO-OTOLOGIE, 2023, 102 (03) : 186 - 193
  • [33] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Jessica Moskovitz
    Jennifer Moy
    Robert L. Ferris
    Current Oncology Reports, 2018, 20
  • [34] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Schoppy, David W.
    Sunwoo, John B.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (06) : 1033 - +
  • [35] Nivolumab in squamous cell carcinoma of the head and neck
    Specenier, Pol
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (05) : 409 - 420
  • [36] Chemoprevention of squamous cell carcinoma of the head and neck
    Wrangle, John M.
    Khuri, Fadlo R.
    CURRENT OPINION IN ONCOLOGY, 2007, 19 (03) : 180 - 187
  • [37] Pharmacotherapy of head and neck squamous cell carcinoma
    Pan, Quintin
    Gorin, Michael A.
    Teknos, Theodoros N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (14) : 2291 - 2302
  • [38] Squamous cell carcinoma of the head and neck in children
    Dombrowski, Natasha D.
    Wolter, Nikolaus E.
    Irace, Alexandria L.
    Robson, Caroline D.
    Perez-Atayde, Antonio R.
    Mack, Jennifer W.
    Rahbar, Reza
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2019, 117 : 131 - 137
  • [39] Basaloid squamous cell carcinoma of the head and neck
    Paulino, AFG
    Singh, B
    Shah, JP
    Huvos, AG
    LARYNGOSCOPE, 2000, 110 (09): : 1479 - 1482
  • [40] MicroRNAs and cell proliferation in head and neck squamous cell carcinoma
    Flavia M Andreghetto
    Maria FG Klingbeil
    Renata M Soares
    Décio S Pinto-Junior
    Mônica B Mathor
    Fábio D Nunes
    Patricia Severino
    BMC Proceedings, 7 (Suppl 2)